Quanterix

$75.75
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.98 (+2.68%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Quanterix and other stocks, options, and ETFs commission-free!

About QTRX

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its Single Molecule Array (Simoa) technology platform uses single molecule measurements to access previously undetectable proteins. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA. The listed name for QTRX is Quanterix Corporation Common Stock.

CEO

E. Kevin Hrusovsky

Employees

248

Headquarters

Billerica, Massachusetts

Founded

2007

Market Cap

2.69B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

437.92K

High Today

$77.91

Low Today

$72.25

Open Price

$74.55

Volume

515.64K

52 Week High

$92.57

52 Week Low

$10.90

QTRX Earnings

-$0.46

-$0.28

-$0.11

$0.07

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Available Mar 2, After Hours